Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026

{
  "signal_id": "4a772b56-7240-4b37-95e8-445577ebb92b",
  "signal_type": "news",
  "signal_subtype": "launches",
  "detected_at": "2026-02-06T04:21:00+00:00",
  "company": {
    "name": "Revvity",
    "domain": "revvity.com"
  },
  "data": {
    "url": "https://www.news-medical.net/news/20260205/Revvity-unveils-new-high-impact-discovery-platforms-and-showcases-recent-innovations-at-SLAS2026.aspx",
    "title": "Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026",
    "excerpt": "Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026.\n\nRevvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, are the Opera Phenix OptIQ(TM) high-content screening system, the EnVision Nexus(TM) One multimode plate reader, and the AssayMate(TM) workstation, alongside other recently introduced solutions spanning sample preparation, screening, advanced imaging, and lab automation.\n\nAt booth #612, Revvity will showcase an expanded portfolio of integrated workflow solutions designed to support discovery programs from early screening through data-driven decision making. Solutions debuting at SLAS2026 include:\n\n* Opera Phenix OptIQ high-content screening system: Designed to reduce bottlenecks in phenotypic screening and advanced cellular analysis, this system enables quantitative imaging across complex biological models, including 3D organoids and organ-on-chip systems. Peak camera quantum efficiency has increased from 60 % to 95 %, improving image sensitivity and data quality, and the system is equipped with Phenologic.AI image analysis software that now includes new classification capabilities, such as cell cycle analysis, expanding beyond its previous...",
    "product": "discovery platforms and technologies at SLAS2026",
    "summary": "Revvity, Inc. launches discovery platforms and technologies at SLAS2026.",
    "category": "launches",
    "found_at": "2026-02-06T04:21:00Z",
    "planning": false,
    "image_url": "https://www.news-medical.net/image-handler/picture/2019/5/Drug_use_and_prohibited_substances._-_Image_-_Monika_Gruszewicz_A1_b3acfd6d2daf44ecbd36979af20eb378-620x480.jpg",
    "confidence": 0.2425,
    "assets_tags": [
      "research_and_development"
    ],
    "product_data": {
      "full_text": "discovery platforms and technologies at SLAS2026",
      "fuzzy_match": true
    },
    "product_tags": [
      "online_technology",
      "general_technology"
    ],
    "published_at": "2026-02-06T04:21:00Z",
    "job_title_tags": [
      "general_technology",
      "engineering"
    ],
    "article_sentence": "Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows."
  }
}

curl https://signals.autobound.ai/v1/signals/4a772b56-7240-4b37-95e8-445577ebb92b \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"revvity.com","limit":20}'